Alcon (ALC) Research & Development (2009 - 2026)
Alcon (ALC) posted quarterly Research & Development of -$245.0 million for Q1 2026, up 10.26% on a QoQ basis from -$273.0 million in Q4 2025.
Alcon (ALC) Research & Development (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Research & Development for 11 consecutive years, with -$245.0 million the latest figure, recorded in Q1 2026.
- Quarterly Research & Development changed N/A year-over-year to -$245.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 billion (changed N/A YoY) and the FY2025 annual result came in at -$990.0 million, down 13.01% from the prior year.
- Research & Development rose to -$245.0 million in Q1 2026 per ALC's latest filing, from -$273.0 million in the prior quarter.
- Over the last five years, Research & Development for ALC reached as high as -$159.0 million in Q3 2022 and fell as low as -$273.0 million in Q4 2025.
- A 5-year average of -$213.7 million and a median of -$212.5 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 50.0% — and 2023, when it declined 26.42%.
- Year by year, Research & Development stood at -$196.0 million in 2022, then fell by 6.12% to -$208.0 million in 2023, then slipped by 11.54% to -$232.0 million in 2024, then fell by 17.67% to -$273.0 million in 2025, then grew by 10.26% to -$245.0 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered -$245.0 million, -$273.0 million, and -$250.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 139.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -245.00 Mn |
| Dec 31, 2025 | -273.00 Mn |
| Sep 30, 2025 | -250.00 Mn |
| Jun 30, 2025 | -245.00 Mn |
| Dec 31, 2024 | -232.00 Mn |
| Sep 30, 2024 | -225.00 Mn |
| Jun 30, 2024 | -220.00 Mn |
| Mar 31, 2024 | -199.00 Mn |
| Dec 31, 2023 | -208.00 Mn |
| Sep 30, 2023 | -201.00 Mn |
| Jun 30, 2023 | -217.00 Mn |
| Mar 31, 2023 | -202.00 Mn |
| Dec 31, 2022 | -196.00 Mn |
| Sep 30, 2022 | -159.00 Mn |
| Jun 30, 2022 | -181.00 Mn |
| Mar 31, 2022 | -166.00 Mn |
| Dec 31, 2021 | -180.00 Mn |
| Sep 30, 2021 | -318.00 Mn |
| Jun 30, 2021 | -178.00 Mn |
| Mar 31, 2021 | -166.00 Mn |